Cécile Bauche
Company: Alaya Bio
Job title: Founder, CSO
Seminars:
From NEXT to NICE: From Nanoparticles-based Ex vivo Therapeutics to Nanoparticles-based In vivo Cell Engineering 3:30 pm
• Hybrid/polymeric nanoparticles as a solution to improve CAR T-cell manufacturing process and CAR T-cell product attributes. • Key performance criteria for an ideal in vivo CAR re-infusable product • Translational hurdles from ex vivo to in vivo CARsRead more
day: Day 1
Panel Discussion: To Build or Not to Build? Rethinking Manufacturing Strategies for an In-Vivo Product 4:00 pm
• Comparing advantages/disadvantages of viral versus non-viral manufacturing • Determining if/when to internalize production due to specificity of in-vivo product • Exploring factors such as time for techRead more
day: Day 1